AH
AMIT KUMAR HALDER
University of Porto, University of KwaZulu-Natal, Jadavpur University, BENGAL COLLEGE OF PHARMACEUTICAL SCIENCES AND RESEARCH
Employment
-
University of Porto POST DOCTORAL INVESTIGATOR2017 - Present
-
University of KwaZulu-Natal POST DOCTORAL RESEARCH SCHOLAR2016 - 2017
-
BENGAL COLLEGE OF PHARMACEUTICAL SCIENCES AND RESEARCH ASSISTANT PROFESSOR2016 - 2016
-
DR. B. C. ROY COLLEGE OF PHARMACY AND ALLIED HEALTH SCIENCES ASSISTANT PROFESSOR2008 - 2011
Education
-
Jadavpur University DOCTOR OF PHARMACY2011 - 2015
-
Jadavpur University MASTER OF PHARMACY2006 - 2008
-
Jadavpur University BACHELOR OF PHARMACY2002 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (66)
- Toward Development of “FXR PREDICTOR”: A Web‐Based Application for Estimating Biological Activity of Chemical Compounds Toward Farnesoid X Receptor Save
- Mechanistic Mapping of Aquatic Toxicity of Per- and Poly-fluoroalkyl Substances: Machine Learning-Driven Approach for Environmental Risk Assessment of 'Forever-Chemicals' Save
- Comprehensive In Silico Investigation of Coumarin Derivatives as Androgen Receptor Antagonists: Ligand‐Based Modeling, MolSHAP‐Driven Design and Molecular Dynamics Validation Save
- Machine Learning-Guided Prediction of Activation Energies for Catalyst Design in the Water Gas Shift Reaction Save
- Predicting the Aquatic Toxicity of Pharmaceutical and Personal Care Products: A Multitasking Modeling Approach Save
- Artificial Intelligence-Driven Modeling for Hydrogel Three-Dimensional Printing: Computational and Experimental Cases of Study Save
- Machine learning-driven prediction of deep eutectic solvents’ heat capacity for sustainable process design Save
- AI Driven Modelling for Hydrogel 3D-Printing: Computational and Experimental Cases of Study Save
- Unveiling structural determinants for FXR antagonism in 1,3,4-trisubstituted-Pyrazol amide derivatives: A multi-scale in silico modelling approach Save
- Shaping the Future of Obesity Treatment: In Silico Multi-Modeling of IP6K1 Inhibitors for Obesity and Metabolic Dysfunction Save